Revvity stock heads into the open after a 9.1% jump

At the close on September 16, 2026, Revvity stock finished at USD 140.19 on the NYSE, up 9.1%, outpacing the S&P 500 in a session marked by broader market losses. Traders now watch upcoming October earnings as a potential next catalyst.

Revvity stock closed at USD 140.19 on the NYSE on September 16, 2026, gaining 9.1% versus the prior session. Per NYSE data, this move came on a day when major US equity benchmarks, including the S&P 500, finished lower, so the stock clearly bucked the wider market trend. As Zacks reported on September 16, 2026, the shares have also delivered a double-digit gain over the past four weeks, emphasizing the recent momentum ahead of the next earnings release expected in late October.

September 16, 2026 in numbers

Revvity Inc. (ISIN US76155R1086, NYSE: RVTY) ended the September 16, 2026 session at USD 140.19, up 9.1% on the day according to data cited by Zacks. The same report highlighted that this performance compares with a 10.6% gain over the past four weeks, showing that the latest move added significantly to an already positive short-term trend. In the broader market, the S&P 500 fell about 0.6% on September 16, 2026, as documented by Economic Times, so Revvity outperformed the benchmark by almost 10 percentage points in that session.

While detailed intraday high and low figures for Revvity on September 16, 2026 are not broken out in the available reports, the company was noted among life sciences and biotech names trading near 52-week highs. RTTNews reported on September 16, 2026 that Revvity shares touched a 52-week high of USD 140.21 intraday, with the session ending up a little over 9%, which implies the close was essentially at that high. This means the September 16, 2026 close left the stock right at its 52-week peak, underscoring strong demand despite a negative day for the wider market.

Outlook for today

Looking ahead to today, September 17, 2026, investors have an eye on the next scheduled earnings release, even though it is still several weeks away. An earnings calendar compiled by eToro lists Revvity as due to report its upcoming quarterly results on October 26, 2026 before the market open, a date that will likely serve as the next major fundamental checkpoint for the stock. Until then, traders may continue to respond primarily to broader market signals and sector sentiment in life sciences and biotech, especially given that the strong September 16, 2026 session coincided with a move to fresh 52-week highs.